Kirin Holdings Company, Limited Share Price

Equities

2503

JP3258000003

Brewers

Market Closed - Japan Exchange 07:00:00 26/04/2024 BST 5-day change 1st Jan Change
2,273 JPY +0.04% Intraday chart for Kirin Holdings Company, Limited +2.60% +10.02%

Financials

Sales 2024 * 2,238B 14.13B 1,131B Sales 2025 * 2,290B 14.46B 1,158B Capitalization 1,841B 11.62B 931B
Net income 2024 * 132B 831M 66.57B Net income 2025 * 142B 896M 71.73B EV / Sales 2024 * 1.05 x
Net Debt 2024 * 516B 3.26B 261B Net Debt 2025 * 490B 3.09B 248B EV / Sales 2025 * 1.02 x
P/E ratio 2024 *
14 x
P/E ratio 2025 *
12.9 x
Employees 30,183
Yield 2024 *
3.16%
Yield 2025 *
3.39%
Free-Float 86.88%
More Fundamentals * Assessed data
Dynamic Chart
Nightingale Health Closes Purchase of Japan's Welltus MT
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited. CI
Finland-based Nightingale Health to Buy Japan's Welltus MT
Nightingale Health Oyj agreed to acquire Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited. CI
B9 Beverages Private Limited announced that it has received INR 4.14086 billion in funding from Tiger Pacific Capital LP, Kirin Holdings Company, Limited CI
B9 Beverages Private Limited announced that it expects to receive INR 4.14086 billion in funding Kirin Holdings Company, Limited CI
Kirin's Profit Up 1.5% in Fiscal 2023 MT
Japan's Kirin names executive Minakata as new president RE
Japan's Kirin to name executive Takeshi Minakata as new president - Nikkei RE
Kirin sees Japan whisky 'renaissance' driving 50% export of premium brand RE
'Daigou' goes corporate as retailers seek new ways to reach Chinese shoppers RE
Japanese whisky turns 100 as craft distilleries transform industry RE
Kirin Logs Lower Nine-Month Attributable Profit Amid Increased Costs MT
L Catterton Partners completed the acquisition of Thorne HealthTech, Inc. from Mitsui & Co., Ltd., Kirin Holdings Company, Limited, Helsinn Therapeutics (U.S.), Inc., Diversified Natural Products, Inc. and others. CI
L Catterton Partners entered into a definitive agreement to acquire Thorne HealthTech, Inc. from Mitsui & Co., Ltd., Kirin Holdings Company, Limited, Helsinn Therapeutics (U.S.), Inc., Diversified Natural Products, Inc. and others for approximately $620 million. CI
More news
1 day+0.04%
1 week+2.60%
Current month+8.34%
1 month+8.16%
3 months+8.91%
6 months+8.26%
Current year+10.02%
More quotes
1 week
2 226.00
Extreme 2226
2 298.00
1 month
2 076.50
Extreme 2076.5
2 298.00
Current year
2 026.50
Extreme 2026.5
2 298.00
1 year
1 983.00
Extreme 1983
2 298.00
3 years
1 739.00
Extreme 1739
2 335.00
5 years
1 739.00
Extreme 1739
2 591.00
10 years
1 311.50
Extreme 1311.5
3 199.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 28/02/15
President 62 31/12/12
Director/Board Member 61 31/03/85
Members of the board TitleAgeSince
Director/Board Member 77 28/02/15
Director/Board Member 74 29/02/20
Director/Board Member 68 29/02/20
More insiders
Date Price Change Volume
26/04/24 2,273 +0.04% 2,864,900
25/04/24 2,272 -0.09% 2,812,700
24/04/24 2,274 -0.22% 3,344,300
23/04/24 2,279 +0.49% 3,594,900
22/04/24 2,268 +2.37% 3,587,400

Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am

More quotes
Kirin Holdings Company, Limited is a holding company organized around 3 areas of activity: - production of beverages (61.6% of net sales): beers, wines and liqueurs (brands Budweiser, Guinness, Heineken, Franzia, Frontera, etc.), carbonated beverages (brands Kirin Lemon), fruit juices (Kirin Tropicana), mineral water (Volvic and Kirin Alkali-Ion-no-Mizu), coffees (Kirin Fire), teas (Kirin Gogo-no-kocha), dairy products etc.; - manufacturing of pharmaceutical products (19.3%): especially for anemia and allergies treatment; - other (19.1%) : mainly manufacturing of food products (seasonings, food additives, etc.). Net sales break down geographically as follows: Japan (64.1%), Oceania (9.6%), America (17.5%) and other (8.8%).
Sector
Brewers
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,273 JPY
Average target price
2,291 JPY
Spread / Average Target
+0.78%
Consensus